Jobs
Senior Engineer, Digital Transformation – MedTech R&D
6 Locations
·
On-site
·
Full-time
·
1w ago
About Johnson & Johnson
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange.
Total Views
0
Apply Clicks
0
Weekly mock applicants
0
Bookmarks
0
Similar jobs
Senior Software Developer, Derivatives
Robinhood · Toronto, Canada
Production Support Mechanical Engineer, Senior
BAE Systems · Merrimack, New Hampshire, United States
Sr. Substrates Development and Ramp Engineer
Intel · Japan, Tokyo
Senior 3GPP RAN1 Standardization Engineer
Google ·
Principal Engineer Systems (I&T)
Northrop Grumman · United States-Florida-Orlando
About Johnson & Johnson
Johnson & Johnson
PublicJohnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange.
10,001+
Employees
New Brunswick
Headquarters
$400B
Valuation
Reviews
4.0
10 reviews
Work-life balance
3.8
Compensation
4.2
Culture
4.1
Career
3.5
Management
4.3
75%
Recommend to a friend
Pros
Supportive and approachable management
Excellent benefits and compensation
Flexible work arrangements and work-life balance
Cons
High-pressure and demanding work environment
Slow bureaucratic processes
Heavy workload and high expectations
Salary Ranges
2,250 data points
Junior/L3
Senior/L5
Junior/L3 · Analyst
177 reports
$93,472
total per year
Base
$85,723
Stock
-
Bonus
$7,749
$59,968
$146,648
Interview experience
7 interviews
Difficulty
3.0
/ 5
Duration
14-28 weeks
Interview process
1
Application Review
2
HR Screen
3
Pre-recorded/Video Interview
4
Technical/Panel Interview
5
Final Interview
6
Offer
Common questions
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
News & Buzz
Johnson & Johnson to launch on TrumpRx with four of its prescription drugs, CBS News reports - Reuters
Reuters
News
·
1d ago
Johnson & Johnson to launch on TrumpRx with 4 of its prescription drugs - CBS News
CBS News
News
·
1d ago
Phase III data show J&J’s Imaavy provides long-term disease control for people with gMG - The Pharma Letter
The Pharma Letter
News
·
2d ago
Cramer's Stop Trading: Johnson & Johnson - CNBC
CNBC
News
·
2d ago